Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Allogene Therapeutics Inc (NASDAQ: ALLO) was $1.28 for the day, up 1.59% from the previous closing price of $1.26. In other words, the price has increased by $1.59 from its previous closing price. On the day, 2.91 million shares were traded. ALLO stock price reached its highest trading level at $1.33 during the session, while it also had its lowest trading level at $1.255.
Ratios:
Our analysis of ALLO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.71 and its Current Ratio is at 9.71. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.21.
On March 14, 2025, Citizens JMP Upgraded its rating to Mkt Outperform which previously was Mkt Perform but kept the price unchanged to $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 10 ’25 when MESSEMER DEBORAH M. sold 36,885 shares for $1.42 per share. The transaction valued at 52,377 led to the insider holds 107,431 shares of the business.
MESSEMER DEBORAH M. bought 36,885 shares of ALLO for $52,391 on Jun 10 ’25. On Apr 21 ’25, another insider, Yoshiyama Annie, who serves as the SVP, Finance of the company, sold 9,601 shares for $1.41 each. As a result, the insider received 13,537 and left with 130,663 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 279975680 and an Enterprise Value of 56045816.
Stock Price History:
The Beta on a monthly basis for ALLO is 0.35, which has changed by -0.5704698 over the last 52 weeks, in comparison to a change of 0.1116153 over the same period for the S&P500. Over the past 52 weeks, ALLO has reached a high of $3.78, while it has fallen to a 52-week low of $0.86. The 50-Day Moving Average of the stock is 1.89%, while the 200-Day Moving Average is calculated to be -32.52%.
Shares Statistics:
ALLO traded an average of 3.22M shares per day over the past three months and 4204260 shares per day over the past ten days. A total of 218.60M shares are outstanding, with a floating share count of 149.51M. Insiders hold about 31.65% of the company’s shares, while institutions hold 65.99% stake in the company. Shares short for ALLO as of 1749772800 were 26041918 with a Short Ratio of 8.24, compared to 1747267200 on 27361306. Therefore, it implies a Short% of Shares Outstanding of 26041918 and a Short% of Float of 14.42.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 10.0 analysts are dedicated to thoroughly evaluating and rating the performance of Allogene Therapeutics Inc (ALLO) in the stock market.The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.19 and low estimates of -$0.29.
Analysts are recommending an EPS of between -$0.74 and -$1.2 for the fiscal current year, implying an average EPS of -$1.0. EPS for the following year is -$0.99, with 10.0 analysts recommending between -$0.55 and -$1.47.
